PLEASANTON, Calif., May 23, 2019 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) 510(k) clearance for the cobas® TV/MG test for use on the ...
- With the new cobas EBV and cobas BKV Tests on the cobas 6800/8800 Systems, healthcare professionals can now determine which transplant patients are at risk of further complications caused by ...
- Immunocompromised transplant recipients are at risk of major complications when infected with adenovirus, a common and highly contagious virus - Healthcare professionals can use this new test to ...
Roche announced that the cobas HIV-1 and cobas HCV Tests for use on the cobas 6800/8800 Systems have been awarded World Health Organization (WHO) prequalification. WHO prequalification helps ...
Roche, a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives, announced that its cobas SARS-CoV-2 Qualitative test has received CE mark for the use ...
Roche has received 510(k) clearance with a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver from the US Food and Drug Administration (FDA) for its cobas liat sexually transmitted ...
Used with the cobas® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in diagnosis ...
The Molecular Pathology team developed COVID-19 testing on the Roche Diagnostics cobas 6800 System in just 19 days. (Wayne Tilcock/UC Davis) In January 2020, Nam Tran and his colleagues in the UC ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback